LONRF2P2

Across TCGA pan-cancer cohorts, LONRF2P2 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated LONRF2P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LONRF2P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LONRF2P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

KIRC, LIHC, and UCEC are the cancer types where LONRF2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.325	0.643	.003	18	view →
LIHC	OS	Tertile	All	0.031	0.775	<.001	18	view →
UCEC	OS	Tertile	All	0.090	0.677	.022	18	view →
STAD	OS	Tertile	All	0.573	0.700	.045	6	view →
SKCM	DFS	Tertile	All	1.000	0.718	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

LONRF2P2–KIRC (OS)

Open the KIRC breakdown →